Scryb, Inc. engages in the development of cloud-based platform that focuses on cybersecurity business. The company is headquartered in Toronto, Ontario. The firm specializes in building and scaling technology ventures in applied artificial intelligence (AI), digital health, cybersecurity, and biotech. Its diversified portfolio is anchored by investments in companies such as Cybeats Technologies Corp. (Cybeats Technologies), Glow LifeTech Corp. (Glow), and Raidian Inc. (Raidian). Cybeats Technologies is a cybersecurity company, which automates software bill of materials (SBOM) management through an enterprise SaaS platform, allowing organizations to accelerate vulnerability management and increasing product security posture. Glow is a Canada-based biotechnology company focused on producing nutraceutical and cannabinoid-based products. Glow has rights to the plant-based MyCell Technology delivery system and has two cannabis consumer brands in Canada: MOD and decimal. Raidian is an AI governance platform designed to address the emerging regulatory needs in the AI sector.
Leveraging in-depth analyst evaluations, we have synthesized key insights from expert assessments to present a positive outlook for SCYRF. Analysts highlight solid fundamentals and favorable market sentiment, suggesting upside potential in the near term. Based on this thorough expert analysis, we maintain an optimistic view of this stock. Our conclusion: SCYRF is a Buy candidate.
SCYRF stock price ended at $0.07 on 星期一, after dropping 12.50%
On the latest trading day Feb 09, 2026, the stock price of SCYRF fell by 12.50%, dropping from $0.07 to $0.07. During the session, the stock saw a volatility of 0.00%, with prices oscillating between a daily low of $0.07 and a high of $0.07. On the latest trading day, the trading volume for SCYRF rose by 549 shares, despite the declining prices. This uptick in volume may signal heightened risk in the near term. In total, 849 shares were traded, with a market value of approximately $3.2M.